vs
Side-by-side financial comparison of EZCORP INC (EZPW) and HAEMONETICS CORP (HAE). Click either name above to swap in a different company.
EZCORP INC is the larger business by last-quarter revenue ($382.0M vs $346.4M, roughly 1.1× HAEMONETICS CORP). HAEMONETICS CORP runs the higher net margin — 28.1% vs 11.6%, a 16.5% gap on every dollar of revenue. On growth, EZCORP INC posted the faster year-over-year revenue change (19.3% vs 4.8%). HAEMONETICS CORP produced more free cash flow last quarter ($209.9M vs $31.7M). Over the past eight quarters, EZCORP INC's revenue compounded faster (15.6% CAGR vs 1.5%).
EZCORP, Inc. is an American pawn shop operator based in Austin, Texas which provides services across the United States and Latin America. It is a publicly traded company listed on the NASDAQ stock exchange and is the second largest pawn shop operator in the U.S. after Cash America International.
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
EZPW vs HAE — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2026
| Metric | | |
|---|---|---|
| Revenue | $382.0M | $346.4M |
| Net Profit | $44.3M | $97.3M |
| Gross Margin | 58.4% | 57.2% |
| Operating Margin | 15.9% | 36.1% |
| Net Margin | 11.6% | 28.1% |
| Revenue YoY | 19.3% | 4.8% |
| Net Profit YoY | 42.8% | — |
| EPS (diluted) | $0.55 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $346.4M | ||
| Q4 25 | $382.0M | $339.0M | ||
| Q3 25 | $336.8M | $327.3M | ||
| Q2 25 | $311.0M | $321.4M | ||
| Q1 25 | $306.3M | $330.6M | ||
| Q4 24 | $320.2M | $348.5M | ||
| Q3 24 | $294.6M | $345.5M | ||
| Q2 24 | $281.4M | $336.2M |
| Q1 26 | — | $97.3M | ||
| Q4 25 | $44.3M | $44.7M | ||
| Q3 25 | $26.7M | $38.7M | ||
| Q2 25 | $26.5M | $34.0M | ||
| Q1 25 | $25.4M | $58.0M | ||
| Q4 24 | $31.0M | $37.5M | ||
| Q3 24 | $15.2M | $33.8M | ||
| Q2 24 | $17.9M | $38.4M |
| Q1 26 | — | 57.2% | ||
| Q4 25 | 58.4% | 59.7% | ||
| Q3 25 | 59.0% | 59.5% | ||
| Q2 25 | 59.1% | 59.8% | ||
| Q1 25 | 58.3% | 58.4% | ||
| Q4 24 | 57.9% | 55.5% | ||
| Q3 24 | 59.5% | 54.2% | ||
| Q2 24 | 59.2% | 52.0% |
| Q1 26 | — | 36.1% | ||
| Q4 25 | 15.9% | 19.9% | ||
| Q3 25 | 11.0% | 17.9% | ||
| Q2 25 | 11.6% | 16.8% | ||
| Q1 25 | 11.2% | 21.6% | ||
| Q4 24 | 13.1% | 16.9% | ||
| Q3 24 | 8.8% | 15.0% | ||
| Q2 24 | 7.9% | 11.8% |
| Q1 26 | — | 28.1% | ||
| Q4 25 | 11.6% | 13.2% | ||
| Q3 25 | 7.9% | 11.8% | ||
| Q2 25 | 8.5% | 10.6% | ||
| Q1 25 | 8.3% | 17.5% | ||
| Q4 24 | 9.7% | 10.8% | ||
| Q3 24 | 5.2% | 9.8% | ||
| Q2 24 | 6.4% | 11.4% |
| Q1 26 | — | — | ||
| Q4 25 | $0.55 | $0.95 | ||
| Q3 25 | $0.35 | $0.81 | ||
| Q2 25 | $0.34 | $0.70 | ||
| Q1 25 | $0.33 | $1.17 | ||
| Q4 24 | $0.40 | $0.74 | ||
| Q3 24 | $0.20 | $0.66 | ||
| Q2 24 | $0.25 | $0.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $465.9M | $245.4M |
| Total DebtLower is stronger | $518.6M | $1.2B |
| Stockholders' EquityBook value | $1.1B | $796.3M |
| Total Assets | $2.0B | $2.4B |
| Debt / EquityLower = less leverage | 0.48× | 1.53× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.4M | ||
| Q4 25 | $465.9M | $363.4M | ||
| Q3 25 | $469.5M | $296.4M | ||
| Q2 25 | $472.1M | $292.9M | ||
| Q1 25 | $505.2M | $306.8M | ||
| Q4 24 | $174.5M | $320.8M | ||
| Q3 24 | $170.5M | $299.3M | ||
| Q2 24 | $218.0M | $344.4M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $518.6M | $1.2B | ||
| Q3 25 | $518.1M | $1.2B | ||
| Q2 25 | $517.6M | $1.2B | ||
| Q1 25 | $620.5M | $1.2B | ||
| Q4 24 | $327.7M | — | ||
| Q3 24 | $327.3M | — | ||
| Q2 24 | $361.3M | — |
| Q1 26 | — | $796.3M | ||
| Q4 25 | $1.1B | $911.5M | ||
| Q3 25 | $1.0B | $849.2M | ||
| Q2 25 | $990.1M | $882.3M | ||
| Q1 25 | $851.6M | $820.8M | ||
| Q4 24 | $823.9M | $906.9M | ||
| Q3 24 | $804.6M | $878.9M | ||
| Q2 24 | $801.5M | $905.4M |
| Q1 26 | — | $2.4B | ||
| Q4 25 | $2.0B | $2.5B | ||
| Q3 25 | $2.0B | $2.4B | ||
| Q2 25 | $1.9B | $2.5B | ||
| Q1 25 | $1.8B | $2.5B | ||
| Q4 24 | $1.5B | $2.5B | ||
| Q3 24 | $1.5B | $2.5B | ||
| Q2 24 | $1.5B | $2.5B |
| Q1 26 | — | 1.53× | ||
| Q4 25 | 0.48× | 1.34× | ||
| Q3 25 | 0.51× | 1.44× | ||
| Q2 25 | 0.52× | 1.39× | ||
| Q1 25 | 0.73× | 1.49× | ||
| Q4 24 | 0.40× | — | ||
| Q3 24 | 0.41× | — | ||
| Q2 24 | 0.45× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $39.1M | $293.2M |
| Free Cash FlowOCF − Capex | $31.7M | $209.9M |
| FCF MarginFCF / Revenue | 8.3% | 60.6% |
| Capex IntensityCapex / Revenue | 2.0% | 9.5% |
| Cash ConversionOCF / Net Profit | 0.88× | 3.01× |
| TTM Free Cash FlowTrailing 4 quarters | $121.7M | $417.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $293.2M | ||
| Q4 25 | $39.1M | $93.6M | ||
| Q3 25 | $51.3M | $111.3M | ||
| Q2 25 | $34.8M | $17.4M | ||
| Q1 25 | $36.9M | $116.6M | ||
| Q4 24 | $26.0M | $43.8M | ||
| Q3 24 | $43.3M | $48.8M | ||
| Q2 24 | $33.7M | $-27.4M |
| Q1 26 | — | $209.9M | ||
| Q4 25 | $31.7M | $87.2M | ||
| Q3 25 | $35.7M | $106.3M | ||
| Q2 25 | $25.7M | $13.6M | ||
| Q1 25 | $28.6M | $100.9M | ||
| Q4 24 | $20.4M | $35.2M | ||
| Q3 24 | $24.4M | $39.4M | ||
| Q2 24 | $30.5M | $-33.1M |
| Q1 26 | — | 60.6% | ||
| Q4 25 | 8.3% | 25.7% | ||
| Q3 25 | 10.6% | 32.5% | ||
| Q2 25 | 8.3% | 4.2% | ||
| Q1 25 | 9.3% | 30.5% | ||
| Q4 24 | 6.4% | 10.1% | ||
| Q3 24 | 8.3% | 11.4% | ||
| Q2 24 | 10.8% | -9.8% |
| Q1 26 | — | 9.5% | ||
| Q4 25 | 2.0% | 1.9% | ||
| Q3 25 | 4.6% | 1.5% | ||
| Q2 25 | 2.9% | 1.2% | ||
| Q1 25 | 2.7% | 4.7% | ||
| Q4 24 | 1.8% | 2.5% | ||
| Q3 24 | 6.4% | 2.7% | ||
| Q2 24 | 1.1% | 1.7% |
| Q1 26 | — | 3.01× | ||
| Q4 25 | 0.88× | 2.09× | ||
| Q3 25 | 1.92× | 2.88× | ||
| Q2 25 | 1.31× | 0.51× | ||
| Q1 25 | 1.45× | 2.01× | ||
| Q4 24 | 0.84× | 1.17× | ||
| Q3 24 | 2.85× | 1.44× | ||
| Q2 24 | 1.88× | -0.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EZPW
| Merchandise | $210.1M | 55% |
| Pawn Service | $131.9M | 35% |
| Jewelry Scrap | $39.9M | 10% |
HAE
| Hospital | $159.6M | 46% |
| Plasma | $130.3M | 38% |
| Blood Center | $56.4M | 16% |
